Breaking News Instant updates and real-time market news.

CHRS

Coherus Biosciences

$25.25

-0.53 (-2.06%)

17:55
10/06/16
10/06
17:55
10/06/16
17:55

Coherus Biosciences says FDA accepts 351(k) BLA for CHS-1701

Coherus BioSciences announced that the U.S. FDA has accepted the filing of 351(k) Biologics License Application for CHS-1701, a pegfilgrastim biosimilar candidate. The BLA submission is supported by similarity data from analytical, pharmacokinetic, pharmacodynamic and immunogenicity studies comparing CHS-1701 and Neulasta. The biosimilar user fee act action date is June 9, 2017.

  • 06

    Nov

CHRS Coherus Biosciences
$25.25

-0.53 (-2.06%)

05/10/16
COWN
05/10/16
NO CHANGE
Target $45
COWN
Outperform
Cowen sees potential for significant value creation at Coherus Biosciences
Cowen said Coherus Biosciences has multiple upcoming triggers which could result in significant value creation for shareholders. The firm noted the company has three biosimilar products in late stage development with others soon to enter the clinic. Cowen reiterated its Outperform rating and $45 price target on Coherus shares.
07/27/16
SBSH
07/27/16
INITIATION
Target $36
SBSH
Buy
Coherus Biosciences initiated with a Buy at Citi
Citi analyst Mohit Bansal started Coherus Biosciences with a Buy rating and $36 price target. Neulasta and Humira biosimilar clarity in the next 12 months should provide upside, the analyst contends.
07/27/16
07/27/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. TAL Education (XRS) initiated with a Buy at Brean Capital. 2. Coherus Biosciences (CHRS) initiated with a Buy at Citi. 3. Verso Corp. (VRS) initiated with a Buy at BWS Financial. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/07/16
MAXM
09/07/16
INITIATION
Target $43
MAXM
Buy
Coherus Biosciences initiated with a Buy at Maxim
Maxim analyst Jason McCarthy initiated Coherus Biosciences with a Buy and $43 price target.

TODAY'S FREE FLY STORIES

SEAS

SeaWorld

$19.21

-0.03 (-0.16%)

07:00
02/21/17
02/21
07:00
02/21/17
07:00
Earnings
Breaking Earnings news story on SeaWorld »

SeaWorld reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TVPT

Travelport

$14.14

-0.06 (-0.42%)

06:58
02/21/17
02/21
06:58
02/21/17
06:58
Earnings
Travelport reports Q4 adjusted EPS 23c, consensus 20c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

MDT

Medtronic

$78.88

0.89 (1.14%)

06:58
02/21/17
02/21
06:58
02/21/17
06:58
Earnings
Medtronic reports Q3 EPS $1.12, consensus $1.11 »

Reports Q3 revenue $7.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 27

    Feb

  • 27

    Feb

  • 07

    Mar

  • 17

    Mar

  • 21

    Mar

REXR

Rexford Industrial

$22.92

0.24 (1.06%)

06:57
02/21/17
02/21
06:57
02/21/17
06:57
Hot Stocks
Rexford Industrial acquires industrial property in Los Angeles for $17.1M »

Rexford Industrial Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOXO

Loxo Oncology

$41.74

0.36 (0.87%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Hot Stocks
Loxo Oncology completes enrollment for larotrectinib NDA »

Loxo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$30.37

-0.08 (-0.26%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Periodicals
GE succession plan near top of investors' minds, WSJ says »

General Electric CEO Jeff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Apr

JELD

JELD-WEN Holding

$29.48

0.48 (1.66%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Initiation
JELD-WEN Holding initiated  »

JELD-WEN Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVN

Trevena

$7.13

0.1 (1.42%)

06:55
02/21/17
02/21
06:55
02/21/17
06:55
Hot Stocks
Breaking Hot Stocks news story on Trevena »

Trevena trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 21

    Mar

TIF

Tiffany

$86.18

3.17 (3.82%)

06:54
02/21/17
02/21
06:54
02/21/17
06:54
Hot Stocks
Tiffany, JANA Partners announce agreement to appoint 3 new independent directors »

Tiffany and JANA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENBL

Enable Midstream

$16.73

0.11 (0.66%)

06:54
02/21/17
02/21
06:54
02/21/17
06:54
Hot Stocks
Breaking Hot Stocks news story on Enable Midstream »

Enable Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ENBL

Enable Midstream

$16.73

0.11 (0.66%)

06:53
02/21/17
02/21
06:53
02/21/17
06:53
Earnings
Enable Midstream reports Q4 EPS 14c, consensus 18c »

Reports Q4 revenue $614M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WLK

Westlake Chemical

$61.66

-0.99 (-1.58%)

06:51
02/21/17
02/21
06:51
02/21/17
06:51
Earnings
Westlake Chemical reports Q4 EPS 76c with items, consensus 80c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

JNCE

Jounce Therapeutics

$19.90

0.24 (1.22%)

06:51
02/21/17
02/21
06:51
02/21/17
06:51
Initiation
Jounce Therapeutics initiated  »

Jounce Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

JELD-WEN Holding

$29.48

0.48 (1.66%)

06:50
02/21/17
02/21
06:50
02/21/17
06:50
Initiation
JELD-WEN Holding initiated  »

JELD-WEN Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDR

EdR

$40.69

-0.06 (-0.15%)

06:48
02/21/17
02/21
06:48
02/21/17
06:48
Earnings
EdR reaffirms FY17 EPS view 66c-76c, consensus 63c »

Sees FY17 core FFO per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HURN

Huron

$42.60

-4 (-8.58%)

06:48
02/21/17
02/21
06:48
02/21/17
06:48
Downgrade
Huron rating change  »

Huron downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

EDR

EdR

$40.69

-0.06 (-0.15%)

06:47
02/21/17
02/21
06:47
02/21/17
06:47
Earnings
EdR reports Q4 EPS 19c, consensus 23c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

MCO

Moody's

$112.90

2.68 (2.43%)

06:45
02/21/17
02/21
06:45
02/21/17
06:45
Downgrade
Moody's rating change  »

Moody's downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 02

    Mar

  • 05

    Mar

RIC

Richmont Mines

$9.30

-0.2 (-2.11%)

06:45
02/21/17
02/21
06:45
02/21/17
06:45
Earnings
Richmont Mines reports Q4 EPS 1c, consensus 4c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LMOS

Lumos Networks

$15.23

0.09 (0.59%)

, ZAYO

Zayo Group

$30.83

-0.16 (-0.52%)

06:41
02/21/17
02/21
06:41
02/21/17
06:41
Downgrade
Lumos Networks, Zayo Group, GTT Communications rating change  »

Lumos Networks downgraded…

LMOS

Lumos Networks

$15.23

0.09 (0.59%)

ZAYO

Zayo Group

$30.83

-0.16 (-0.52%)

GTT

GTT Communications

$29.00

-0.05 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AER

AerCap

$46.65

-0.14 (-0.30%)

06:41
02/21/17
02/21
06:41
02/21/17
06:41
Hot Stocks
AerCap approves $350M share repurchase program »

Company authorized a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGEN

Miragen Therapeutics

$11.80

0.79 (7.18%)

06:40
02/21/17
02/21
06:40
02/21/17
06:40
Initiation
Miragen Therapeutics initiated  »

Miragen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AER

AerCap

$46.65

-0.14 (-0.30%)

06:40
02/21/17
02/21
06:40
02/21/17
06:40
Hot Stocks
Breaking Hot Stocks news story on AerCap »

AerCap reports Q4 $49.33…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AER

AerCap

$46.65

-0.14 (-0.30%)

06:39
02/21/17
02/21
06:39
02/21/17
06:39
Earnings
AerCap reports Q4 non GAAP EPS $2.01, consensus $1.68 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WATT

Energous

$15.47

-1.31 (-7.81%)

, AVGO

Broadcom

$210.41

2.23 (1.07%)

06:39
02/21/17
02/21
06:39
02/21/17
06:39
Recommendations
Cowen says Energous 'exceedingly unlikely' to power Apple charging »

Supply chain channel…

WATT

Energous

$15.47

-1.31 (-7.81%)

AVGO

Broadcom

$210.41

2.23 (1.07%)

AAPL

Apple

$135.72

0.375 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 08

    Mar

  • 13

    Mar

  • 16

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.